Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma (Q35208375)

7 August 2017

Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma (English)

1 reference

7 August 2017

Julie Teruya-Feldstein

12

object named as

Julie Teruya-Feldstein

0 references

Jonathan H Schatz

object named as

Jonathan H Schatz

1

0 references

Andrew D Zelenetz

object named as

Andrew D Zelenetz

14

0 references

author name string

Elisa Oricchio

2

1 reference

7 August 2017

Andrew L Wolfe

3

1 reference

7 August 2017

Man Jiang

4

1 reference

7 August 2017

Irina Linkov

5

1 reference

7 August 2017

Jocelyn Maragulia

6

1 reference

7 August 2017

Weiji Shi

7

1 reference

7 August 2017

Zhigang Zhang

8

1 reference

7 August 2017

Vinagolu K Rajasekhar

9

1 reference

7 August 2017

Nen C Pagano

10

1 reference

7 August 2017

John A Porco

11

1 reference

7 August 2017

Neal Rosen

13

1 reference

7 August 2017

Jerry Pelletier

15

1 reference

7 August 2017

Hans-Guido Wendel

16

1 reference

7 August 2017

language of work or name

English

0 references

publication date

22 August 2011

1 reference

Journal of Experimental Medicine

7 August 2017

1 reference

7 August 2017

208

1 reference

7 August 2017

9

1 reference

7 August 2017

1799-1807

1 reference

For better or for worse: the role of Pim oncogenes in tumorigenesis

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

mTOR signaling and drug development in cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Pim kinase inhibitors: a survey of the patent literature

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Evaluating temsirolimus activity in multiple tumors: a review of clinical trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Regulation of translation initiation in eukaryotes: mechanisms and biological targets

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Stromal gene signatures in large-B-cell lymphomas

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Tumorigenic activity and therapeutic inhibition of Rheb GTPase

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

mTORC1 promotes survival through translational control of Mcl-1.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Dissecting eIF4E action in tumorigenesis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Microarray-based classification of diffuse large B-cell lymphoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Reverse engineering of regulatory networks in human B cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Pim-1 protein expression is regulated by its 5'-untranslated region and translation initiation factor elF-4E.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

Cancer: mixing cocktails.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171093

VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia

26 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1084%2FJEM.20110846

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

21 January 2018

2 references

Crossref

https://api.crossref.org/works/10.1084%2FJEM.20110846

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/21859846

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21859846

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1084/JEM.20110846

1 reference

7 August 2017

1 reference

7 August 2017

1 reference